Johnson & Johnson shares rose after a judge said it should pay $572 million for its part in Oklahoma’s opioid epidemic. Though the company is appealing, investors might be better off seeing the decision as a warning of more payouts to come, as Robert Cyran explains.
Johnson & Johnson shares rose after a judge said it should pay $572 million for its part in Oklahoma’s opioid epidemic. Though the company is appealing, investors might be better off seeing the decision as a warning of more payouts to come, as Robert Cyran explains.https://reut.rs/2Zr03rj
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »